Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 02, 2021

SELL
$25.79 - $42.11 $567 - $926
-22 Closed
0 $0
Q1 2021

Apr 15, 2021

SELL
$38.75 - $86.92 $11,625 - $26,076
-300 Reduced 93.17%
22 $1,000
Q4 2020

Jan 21, 2021

BUY
$34.61 - $123.66 $10,383 - $37,098
300 Added 1363.64%
322 $14,000
Q3 2020

Oct 06, 2020

BUY
$37.49 - $63.19 $824 - $1,390
22 New
22 $1,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $426M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Optimum Investment Advisors Portfolio

Follow Optimum Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Optimum Investment Advisors with notifications on news.